Evaluation of the Safety, Recovery, Half-Life, and Clinical Efficacy of Antithrombin III (Human) in Patients With Hereditary Antithrombin III Deficiency by Menache, D., O'Malley, J.P., Schorr, J.B., Wagner, B., Williams, C., Alving, the Cooperative Study Group: B.M., Ballard, J.O., Goodnight, S.H., Hathaway, W.E., Hultin, M.B., Kitchens, C.S., Lessner, H.E., Makary, A.Z., Manco-Johnson, M., McGehee, W.G., Penner, J.A., Sanders, J.E.

Get full text